Eyes Achieving Absence of Diabetic Macular Edema and Very Good Vision: A Post Hoc Analysis of DRCR Network Protocol AC

Macular Diseases

Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis

JAMA Ophthalmol

Khan MA, Hill L, Stoilov I, Haller JA

doi: 10.1001/jamaophthalmol.2024.6371

Macular DiseasesFurther Publications

Intravitreal faricimab in patients with refractory diabetic macular edema: 6-month fluid analysis using artificial intelligence

BMC Ophthalmol

Owlya N, Barbosa M, Bartolomeo N, Pannatier-Schuetz Y, Nascimbeni AC, Castro DG, Barry MP, Ambresin A

doi: 10.1186/s12886-026-04651-w

Macular Diseases

Risk of intraocular pressure elevation associated with triamcinolone acetonide administration via different routes in macular edema: a systematic review and network meta-analysis of randomized controlled trials

BMC Ophthalmol

Liu K, Yi J, Xu J, Zhong L, Su N

doi: 10.1186/s12886-025-03979-z

Macular DiseasesSurgery and InterventionCataracts

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema

BMC Ophthalmol

Shen Y, Zhu X, Li AQ, Ji M, Guan HJ

doi: 10.1186/s12886-025-04264-9

Macular DiseasesRetinal Diseases

Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis

Ophthalmology

Nanji K, Grad J, Hatamnejad A, El-Sayes A, Mihalache A, Gemae M, Huang R, Phillips M, Kaiser PK, Munk MR, Garg SJ, Sarraf D, Sadda SR, Fraser-Bell S, Zeraatkar D, Ma J, Borrelli E, Steel DH, Sivaprasad S, Wykoff CC, Chaudhary V

doi: 10.1016/j.ophtha.2025.07.038

Macular DiseasesRetinal Diseases

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Sci Rep

Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y, J-CREST

doi: 10.1038/s41598-025-20300-6

Macular Diseases

Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report

Ophthalmol Sci

Spindler J, Artemiev D, Pfister IB, Schild C, Tillmann A, Heck K, Gabathuler F, Ruscitti L, Spitznagel T, Kitsos-Kalyvianakis K, Munk MR, Hatz K, Zweifel SA, Grimaldi G, Somfai GM, Ambresin A, Weinberger A, Eandi CM, Feltgen N, Kitay A, Ebneter A, Garweg JG

doi: 10.1016/j.xops.2026.101087

Macular Diseases

Anatomic biomarkers as potential endpoints in diabetic macular edema: Systematic literature review with identification of macular volume as a key surrogate for visual acuity

Surv Ophthalmol

Couturier A, Wykoff CC, Lupidi M, Udaondo P, Peto T, Pintard PJ

doi: 10.1016/j.survophthal.2025.04.004

Macular Diseases

Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland

J Med Econ

Ambresin A, Quist SW, Boer M, Maamari S, Barthelmes D

doi: 10.1080/13696998.2025.2536420

Related content

Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis

Intravitreal faricimab in patients with refractory diabetic macular edema: 6-month fluid analysis using artificial intelligence

Risk of intraocular pressure elevation associated with triamcinolone acetonide administration via different routes in macular edema: a systematic review and network meta-analysis of randomized controlled trials

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema

Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report

Anatomic biomarkers as potential endpoints in diabetic macular edema: Systematic literature review with identification of macular volume as a key surrogate for visual acuity

Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland